Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gene therapy
|
| gptkbp:amendedBy |
gene-edited
|
| gptkbp:antigen |
gptkb:BCMA
|
| gptkbp:clinicalTrialPhase |
Phase 1/2a
|
| gptkbp:developedBy |
Precision BioSciences
|
| https://www.w3.org/2000/01/rdf-schema#label |
PBCAR269A
|
| gptkbp:indication |
multiple myeloma
|
| gptkbp:manufacturingPlatform |
ARCUS genome editing
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
clinical development
|
| gptkbp:treatment |
allogeneic CAR-T
|
| gptkbp:bfsParent |
gptkb:Precision_Biosciences
|
| gptkbp:bfsLayer |
7
|